PreveCeutical Medical Inc.
PREV
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -532.10K | -172.60K | -246.20K | -264.50K | -174.60K |
| Total Depreciation and Amortization | 2.20K | 1.80K | 1.90K | 1.80K | 1.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.70K | 106.90K | 63.80K | 57.90K | 58.60K |
| Change in Net Operating Assets | 309.50K | 16.70K | 98.60K | 65.50K | 70.80K |
| Cash from Operations | -72.70K | -47.10K | -81.90K | -139.30K | -43.30K |
| Capital Expenditure | -- | -500.00 | -100.00 | -100.00 | -600.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.00K | -- | -- | -- | -- |
| Cash from Investing | -40.00K | -500.00 | -100.00 | -100.00 | -600.00 |
| Total Debt Issued | 58.90K | 83.20K | 22.80K | 156.00K | 60.40K |
| Total Debt Repaid | -- | -1.50K | -1.00K | -72.00K | -- |
| Issuance of Common Stock | 50.00K | 43.90K | 90.00K | 105.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 75.90K | 89.70K | 82.00K | 138.70K | 44.80K |
| Foreign Exchange rate Adjustments | -500.00 | -100.00 | 100.00 | -1.20K | 100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.40K | 42.10K | 0.00 | -1.90K | 1.00K |